Franklin Resources
PRTK

Franklin Resources’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Franklin Resources’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-360,000
Closed -$9.04M – 1535
2017
Q3 		$9.04M Sell
360,000
-148,066
-29% -$3.45M ﹤0.01% 971
2017
Q2 		$12.2M Buy
508,066
+262,374
+107% +$5.8M 0.01% 904
2017
Q1 		$4.73M Buy
+245,692
New +$3.87M ﹤0.01% 1115
2014
Q2 		– Sell
-24,450
Closed -$904K – 1582
2014
Q1 		$904K Sell
24,450
-25
-0.1% -$987 ﹤0.01% 1367
2013
Q4 		$987K Hold
24,475
– – ﹤0.01% 1335
2013
Q3 		$934K Hold
24,475
– – ﹤0.01% 1300
2013
Q2 		$887K Buy
+24,475
New +$1.05M ﹤0.01% 1286

Other funds holding PRTK

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Franklin Resources's PRTK Position: Q4 2017 in Review

Franklin Resources sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q4 2017, closing a stake of 360,000 shares — an estimated $9.04M sold.

Franklin Resources first reported a position in PRTK in Q2 2013 and held it in 7 quarters. The position peaked at $12.2M in Q2 2017. 116 funds tracked by Wall St. Rank hold PRTK as of Q4 2017.

  • Franklin Resources reported no remaining Paratek Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Franklin Resources sold 360,000 Paratek Pharmaceuticals, Inc. shares in Q4 2017, an estimated $9.04M.
  • Franklin Resources first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 7 quarters.
  • Franklin Resources's Paratek Pharmaceuticals, Inc. position peaked at $12.2M in Q2 2017.
  • 116 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2017.

Based on Franklin Resources's 13F filing for Q4 2017, filed 14 Feb 2018.